Rheumatology
- Cleveland Clinic—A century of progress
No one in their right mind would want to return to the “good old days.”
- Double the reasons for giving the flu vaccine in 2020
Limiting the impact of other diseases, possibly including COVID-19.
- The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults
Patients can have variable responses to vaccines, depending on the vaccine and the DMARD.
SARS-CoV-2 and myocardial injury: Few answers, many questionsWhat is the mechanism? Is this a distinct population? What are the treatment options?
- Polymyalgia rheumatica: An updated review
Suspect it in older patients with bilateral shoulder and hip stiffness in the morning.
- Perioperative infection: Are we sure what to focus on?
Which immunosuppressive drugs pose the greater danger in the perioperative period: the newer biologics or corticosteroids?
- Off-label and oft-prescribed
When prescribing drugs for uses beyond their FDA indications, we need to explain their anticipated side effects and benefits.
- Beyond depression: Other uses for tricyclic antidepressants
The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.
- A link between A-fib and sleep apnea is no surprise, but why?
The two conditions commonly coexist, and treating the sleep apnea results in better rhythm-directed outcomes in the A-fib.